Current topics in the news regarding human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).
NOW AVAILABLE: 2015 HIV/AIDS Surveillance Reports
Number and demographic characteristics of newly diagnosed HIV/AIDS cases in Minnesota.
- Highlights from the MN HIV Surveillance Report, 2015, with audio narration (PPT presentation)
- Highlights from the MN HIV Surveillance Report, 2015, slides only, no audio narration (PPT)
NOW AVAILABLE: 2015
STD Surveillance Statistics
Graphs, tables and text that describe trends in sexually transmitted diseases (STDs) in Minnesota. Includes data on: Chlamydia, Gonorrhea, Syphilis and Chancroid.
- 2015 STD Surveillance Data Release webinar presentation, with audio narration (PPT presentation)
- 2015 STD Surveillance Data Release webinar presentation, slides only, no audio narration (PPT)
- 2015 STD Surveillance Data Release webinar presentation, slides only, no audio narration (PDF)
Applicationi materials are now available for this funding opportunity.
News Release: Syphilis rates rise among women in Minnesota
Health officials are concerned over a jump in syphilis cases among Minnesota women. Preliminary data for 2015 show syphilis cases in women were up 63 percent compared to 2014. The increase is occurring primarily among women of child-bearing age in all racial and ethnic groups, including pregnant women.
Health Advisory: Syphilis Testing of ALL Pregnant Women (PDF)
Minnesota is seeing a significant increase of infectious and latent syphilis cases among women of all racial and ethnic groups. Eighty percent of all cases in women are concentrated in the Twin Cities metropolitan area and twenty percent in Greater Minnesota. Native American women have the largest increase of 750 percent.
HIV Prevention Request for Proposals (RFP) 2017: Upcoming Changes
There will be no HIV prevention RFP released this year (2016).
MDH will extend its currently funded HIV prevention grantees through December 31, 2017.
Epidemiological Profile of HIV/AIDS in Minnesota
The epidemiological (epi) profile presents data on the HIV epidemic in the state of Minnesota. Updated 12/2015
Ryan White HIV/AIDS Program Part B Proposal Information: Updated
On October 2, 2015, Commissioner Edward Ehlinger of the Minnesota Department of Health (MDH) and Commissioner Lucinda Jesson of the Minnesota Department of Human Services (DHS) issued a joint letter (PDF) announcing the decision to set aside the proposal for now and maintain the current organizational structures in place at DHS and MDH.
Dear Colleague Letter: STD Treatment Guideline Update - MN Dept of Health (PDF)
Overview of the updated CDC Sexually Transmitted Diseases Treatment Guidelines, 9/2015
CDC supports the new World Health Organization (WHO) guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis (PrEP) for HIV
This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral PrEP is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches.
Health officials urging men who have sex with men (MSM) to seek meningococcal vaccination following death of man from meningococcal meningitis
Meningococcal outbreaks among MSM have occurred in Chicago, New York, Los Angeles. July 2015
CDC Health Advisory: Ciprofloxacin- and Azithromycin-Nonsusceptible Shigellosis in the United States
Most cases have been reported among gay, bisexual, and other men who have sex with men (MSM) in Illinois, Minnesota, and Montana and among international travelers, but cases are also occurring among other populations. Shigellosis is very contagious and can spread quickly through communities and across different segments of the population. June 2015
2015 STD Treatment Guidelines available from CDC
Guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) have been updated by the Centers for Disease Control and Prevention (CDC).
Minnesota Treatment Cascade for People Living with HIV/AIDS
As part of the National HIV/AIDS Strategy for the United States, MDH has calculated an HIV treatment cascade using HIV surveillance data. These calculations help us better understand the HIV epidemic and the disparities that exist in the delivery of care among HIV positive people in Minnesota. April 2015
CDC Video: 9 in 10 new US HIV infections come from people not receiving HIV care
Video from the CDC on the importance of getting those unaware of their status in to care
Shigellosis Fact Sheet for Men who have Sex with Men (MSM)
MDH has observed an increase in reported shigellosis infections in Minneapolis among men who have sex with men (MSM). Four (4) cases were diagnosed in November among white, non-Hispanic, MSM. Sexual contact is the likely route of transmission.
MMWRs from the Centers for Disease Control and Prevention (CDC)
- MMWR: HIV Testing and Risk Behaviors Among Gay, Bisexual, and Other Men Who Have Sex with Men — United States
- MMWR: Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012
HIV/AIDS among Men Who Have Sex with Men in Minnesota
Men who have sex with men (MSM) and men who have sex with men and use injection drugs (MSM/IDU) remain at increased risk for HIV infection in MN.
Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota
The Minnesota Chlamydia Partnership (MCP) presents the Strategy for Reducing and Preventing Chlamydia in Minnesota, the first-ever action plan to address the epidemic of chlamydia.
Minnesota African/African-American W MAAAH was formed to establish Black women as a funding priority in the State of Minnesota, address the issue of lack of services specific to Black women and youth, and to ensure sustainability of services for Black women.
CDC's Morbidity and Mortality Weekly Report (MMWR)
This issue of MMWR describes the HIV/AIDS epidemic in the United States and notes important successes and current challenges in the prevention of HIV. Also includes the summary Twenty-Five Years of HIV/AIDS - United States, 1981-2006.
HIV Subtype and Drug Resistance Surveillance
MDH, STD, HIV and TB Section and Public Health Laboratory have incorporated HIV drug resistance and subtype surveillance into routine HIV surveillance.
Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.